UNITED STATES: US Jury Rejects Glaxo Antitrust Claim vs. Abbott
In Oakland, Calif., on Wednesday, a 10-member federal jury rejected GlaxoSmithKline’s (GSK) antitrust claim that Abbott Laboratories had quadrupled the price of its HIV drug Norvir in order to preserve the sales growth of its HIV drug Kaletra. Norvir is used in drug cocktails because it can boost the effectiveness of other HIV medications. Abbott’s [...]
